HOME Top Market Reports Thrombectomy Devices Market by Type (Hydrodynamic, Ultrasound, Aspiration, Mechanical Thrombectomy), Application (Cardiovascular, Peripheral, Neurovascular), End User (Hospitals, Surgical Centers, Ambulatory, Academia, CROs) - Global Forecasts to 2022

Thrombectomy Devices Market by Type (Hydrodynamic, Ultrasound, Aspiration, Mechanical Thrombectomy), Application (Cardiovascular, Peripheral, Neurovascular), End User (Hospitals, Surgical Centers, Ambulatory, Academia, CROs) - Global Forecasts to 2022

By: marketsandmarkets.com
Publishing Date: April 2017
Report Code: MD 5202

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The global thrombectomy devices market is estimated to reach USD 1.45 Billion by 2022; growing at a CAGR of 6.7% during the forecast period. The growing target patient population, ongoing technological advancements, favorable medical reimbursements, rising demand for minimally invasive thrombectomy procedures, and increasing healthcare expenditure across emerging markets are some key factors propelling the growth of this market.

In this report, the market has been segmented on the basis of type, application, end user, and region. Based on application, the cardiovascular segment commanded the largest share of the global thrombectomy devices market in 2016. This large market share is mainly attributed to factors such as increasing prevalence of cardiovascular diseases across major markets, procedural benefits offered by mechanical thrombectomy in cardiac surgeries, higher prevalence of thrombotic diseases among geriatric individuals, and growing preference of surgeons for image-guided and minimally invasive cardiac surgeries.

In 2016, North America held the largest share of the market. However, the developing Asia-Pacific countries including China and India are expected to emerge as the new revenue-generating regions for prominent market players during 2017-2022. The growth of this Asia-Pacific market is attributed to the presence of a large patient population for target diseases, rising awareness among surgeons related to the benefits offered by thrombectomy devices, increasing healthcare expenditure, and rising adoption of these devices due to their decreasing costs.

In 2016, Stryker Corporation (U.S.) held the leading position in the market. Over the past three years, the company has adopted product launches & enhancements, strategic acquisitions, and market expansion as its key business strategies to ensure its dominance in this market. Medtronic plc (Ireland), Boston Scientific Corporation (U.S.), Johnson & Johnson (U.S.), Terumo Corporation (Japan), Penumbra, Inc. (U.S.), Spectranetics Corporation (U.S.), Edwards Lifesciences Corporation (U.S.), Argon Medical Devices, Inc. (U.S.), and Teleflex Incorporated (U.S.), were few other key players operating in the market.

Target Audience

  • Healthcare service providers (hospitals and surgical centers)
  • Non-government organizations
  • Government regulatory authorities
  • Research laboratories and academic institutes
  • Clinical research organizations (CROs)
  • Research and development companies
  • Market research and consulting firms

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

This research report categorizes the thrombectomy devices market into the following segments:

Thrombectomy Devices Market, by Type

  • Mechanical/Fragmentation Thrombectomy Devices
  • Stent Retrievers
  • Basket/Brush Retrievers
  • Coil Retrievers
  • Aspiration Thrombectomy Devices
  • Rheolytic/Hydrodynamic Thrombectomy Devices
  • Ultrasonic Thrombectomy Devices

Thrombectomy Devices Market, by Application

  • Cardiovascular Application
  • Peripheral Vascular Application
  • Neurovascular Application

Thrombectomy Devices Market, by End User

  • Hospitals and Surgical Centers
  • Ambulatory Surgical Centers
  • Research Laboratories & Academic Institutes
  • Other End Users

Thrombectomy Devices Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • RoE
  • Asia-Pacific
    • Japan
    • China
    • India
    • RoAPAC
  • Rest of the World
    • Latin America
    • Middle East & Africa

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for thrombectomy devices market report:

Product Analysis

  • Product Matrix, which gives a detailed comparison of the product portfolios of the top five companies

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

Table of Contents

1 Introduction (Page No. - 17)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Geographic Scope
           1.3.3 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 21)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
    2.2 Opportunity Indicators
                    2.2.1.1 Rising Geriatric Population
                    2.2.1.2 Number of Hospitals and Surgical Centers
                    2.2.1.3 Increased Prevalence of Cardiovascular Diseases
    2.3 Market Size Estimation
           2.3.1 Bottom-Up Approach
           2.3.2 Top-Down Approach
    2.4 Market Breakdown and Data Triangulation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 32)

4 Premium Insights (Page No. - 36)
    4.1 Thrombectomy Devices: Market Snapshot (2017-2022)
    4.2 Regional Analysis Thrombectomy Devices Market, By Application (2016)
    4.3 Regional Analysis: Market Size, By Type (2017 vs 2022)
    4.4 Regional Analysis: Market Size, By End User (2017 vs 2022)
    4.5 Geographic Analysis: Market, By Country (2017-2022)

5 Market Overview (Page No. - 41)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Key Market Drivers
                    5.2.1.1 Growing Target Patient Population
                    5.2.1.2 Ongoing Technological Advancements
                    5.2.1.3 Favorable Medical Reimbursement Scenario
                    5.2.1.4 Increasing Healthcare Expenditure Across Emerging Markets
                    5.2.1.5 Rising Demand for Minimally Invasive Thrombectomy Procedures
           5.2.2 Key Market Restraints
                    5.2.2.1 Stringent Regulatory Scenario
                    5.2.2.2 Limited Patient Awareness Related to Thrombectomy Resulting in Delayed Treatment for Peripheral Vascular Diseases
           5.2.3 Key Market Opportunities
                    5.2.3.1 Increasing Number of Research Activities in the Field of Thrombectomy
                    5.2.3.2 Expanding Application of Ultrasound in Vascular Treatment
           5.2.4 Key Market Challenges
                    5.2.4.1 Limited Availability of Clinical Data to Validate the Therapeutic Efficacy of Clot Retrieval Devices
                    5.2.4.2 Dearth of Skilled and Well-Trained Surgeons
    5.3 Research Pipeline Analysis
           5.3.1 Aspiration Thrombectomy
           5.3.2 Mechanical Thrombectomy
           5.3.3 Rheolytic Thrombectomy
           5.3.4 Ultrasonic Thrombectomy

6 Industry Insights (Page No. - 58)
    6.1 Introduction
    6.2 Supply Chain Analysis
           6.2.1 Major Stakeholders
           6.2.2 Key Influencers
    6.3 Industry Trends
           6.3.1 Growing Adoption of Laser-Assisted Thrombectomy
    6.4 Porter’s Five Forces Analysis
    6.5 Current Reimbursement Scenario in US and Germany (As of December 2016)

7 Global Thrombectomy Devices Market, By Type (Page No. - 64)
    7.1 Introduction
    7.2 Aspiration Thrombectomy Devices
    7.3 Mechanical/Fragmentation Thrombectomy Devices
           7.3.1 Stent Retrievers
           7.3.2 Coil Retrievers
           7.3.3 Basket/Brush Retrievers
    7.4 Rheolytic/Hydrodynamic Thrombectomy Devices
    7.5 Ultrasonic Thrombectomy Devices

8 Global Thrombectomy Devices Market, By Application (Page No. - 75)
    8.1 Introduction
    8.2 Cardiovascular Applications
    8.3 Neurovascular Applications
    8.4 Peripheral Vascular Applications

9 Global Thrombectomy Devices Market, By End User (Page No. - 82)
    9.1 Introduction
    9.2 Hospitals and Surgical Centers
    9.3 Ambulatory Surgical Centers
    9.4 Research Laboratories and Academic Institutes
    9.5 Other End Users

10 Thrombectomy Devices Market, By Region (Page No. - 89)
     10.1 Introduction
     10.2 North America
             10.2.1 U.S.
             10.2.2 Canada
     10.3 Europe
             10.3.1 Germany
             10.3.2 France
             10.3.3 U.K.
             10.3.4 Rest of Europe
     10.4 Asia-Pacific
             10.4.1 Japan
             10.4.2 China
             10.4.3 India
             10.4.4 Rest of Asia-Pacific
     10.5 Rest of the World
             10.5.1 Latin America
             10.5.2 Middle East and Africa (MEA)

11 Competitive Landscape (Page No. - 121)
     11.1 Introduction
     11.2 Vendor Dive Overview
             11.2.1 Vanguards
             11.2.2 Innovators
             11.2.3 Dynamic
             11.2.4 Emerging

*Top 25 Companies Analyzed for This Studies are - Stryker Corporation (U.S.), Boston Scientific Corporation (U.S.), Medtronic PLC (Ireland), Terumo Corporation (Japan), Johnson & Johnson (U.S.), Penumbra, Inc. (U.S.), Spectranetics Corporation (U.S.), Teleflex Incorporated (U.S.), Argon Medical Devices, Inc. (U.S.), Edwards Lifesciences Corporation (U.S.), Straub Medical AG (Switzerland), BTG International (U.K.), Phenox GmbH (Germany), Acandis GmbH Co. & Kg (Germany), Merit Medical Systems, Inc. (U.S.), Minnetronix, Inc. (U.S.) Nexgen Medical Systems, Inc. (U.S.), Capture Vascular (U.S.), Applied Medical (U.S.), Claret Medical (U.S.), Lemaitre Vascular (U.S.), Stentys (France), Dispomedical GmbH( Germany), Control Medical Tecyhnology (U.S.), and Natec Medical Ltd (Mauritius)

12 Company Profiles (Page No. - 125)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     12.1 Introduction
             12.1.1 Geographic Benchmarking
     12.2 Top Market Players
             12.2.1 Stryker Corporation
             12.2.2 Medtronic PLC
             12.2.3 Johnson & Johnson
             12.2.4 Terumo Corporation
             12.2.5 Boston Scientific Corporation
             12.2.6 Spectranetics Corporation
             12.2.7 Penumbra, Inc.
             12.2.8 Argon Medical Devices, Inc.
             12.2.9 Edwards Lifesciences Corporation
             12.2.10 Teleflex Incorporated
     12.3 Emerging Players
             12.3.1 Straub Medical AG
             12.3.2 BTG International Ltd.
             12.3.3 Phenox GmbH
             12.3.4 Acandis GmbH & Co. Kg

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 164)
     13.1 Primary Insights
     13.2 Discussion Guide
     13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.4 Introducing RT: Real-Time Market Intelligence
     13.5 Available Customizations
     13.6 Related Reports
     13.7 Author Details


List of Tables (67 Tables)

Table 1 Aspiration Thrombectomy Catheters: Ongoing Clinical Trials (As of December 2016)
Table 2 Clot Retrievers: Ongoing Clinical Trials (As of December 2016)
Table 3 Stent Retrievers: Ongoing Clinical Trials (As of December 2016)
Table 4 Rheolytic Thrombectomy Devices: Ongoing Clinical Trials (As of December 2016)
Table 5 Ultrasonic Thrombectomy Devices: Ongoing Clinical Trials (As of December 2016)
Table 6 Medical Reimbursements for Thrombectomy Procedures (As of December 2016)
Table 7 Global Thrombectomy Devices Market Size, By Type, 2015–2022 (USD Million)
Table 8 Aspiration Thrombectomy Devices Market Size, By Region, 2015–2022 (USD Million)
Table 9 Mechanical/Fragmentation Thrombectomy Devices Market Size, By Product, 2015–2022 (USD Million)
Table 10 Mechanical/Fragmentation Thrombectomy Devices Market Size, By Region, 2015–2022 (USD Million)
Table 11 Stent Retrievers Market Size, By Region, 2015–2022 (USD Million)
Table 12 Coil Retrievers Market Size, By Region, 2015–2022 (USD Million)
Table 13 Basket/Brush Retrievers Market Size, By Region, 2015–2022 (USD Million)
Table 14 Rheolytic/Hydrodynamic Thrombectomy Devices Market Size,
Table 15 Ultrasonic Thrombectomy Devices Market Size, By Region, 2015–2022 (USD Million)
Table 16 Global Thrombectomy Devices Market Size, By Application, 2015–2022 (USD Million)
Table 17 Market Size, By Region, 2015–2022 (USD Million)
Table 18 Market Size for Cardiovascular Applications, By Region, 2015–2022 (USD Million)
Table 19 Market Size for Neurovascular Applications, By Region, 2015-2022 (USD Million)
Table 20 Market Size for Peripheral Vascular, By Region, 2015-2022 (USD Million)
Table 21 Market Size, By End User, 2015–2022 (USD Million)
Table 22 Market Size, By Region, 2015–2022 (USD Million)
Table 23 Market Size for Hospitals and Surgical Centers, By Region, 2015–2022 (USD Million)
Table 24 Market Size for Ambulatory Surgical Centers, By Region, 2015–2022 (USD Million)
Table 25 Market Size for Research Laboratories and Academic Institutes, By Region, 2015–2022 (USD Million)
Table 26 Thrombectomy Devices Market Size for Other End Users, By Region, 2015–2022 (USD Million)
Table 27 Thrombectomy Devices Market Size, By Region, 2015–2022 (USD Million)
Table 28 North America: Market Size, By Country, 2015–2022 (USD Million)
Table 29 North America: Market Size, By Type, 2015–2022 (USD Million)
Table 30 North America: Market Size, By End User, 2015–2022 (USD Million)
Table 31 North America: Market Size, By Application, 2015–2022 (USD Million)
Table 32 U.S.: Market Size, By Type, 2015–2022 (USD Million)
Table 33 U.S.: Market Size, By Application, 2015–2022 (USD Million)
Table 34 Canada: Market Size, By Type, 2015–2022 (USD Million)
Table 35 Canada: Market Size, By Application, 2015–2022 (USD Million)
Table 36 Europe: Market Size, By Country, 2015–2022 (USD Million)
Table 37 Europe: Market Size, By Type, 2015–2022 (USD Million)
Table 38 Europe: Market Size, By End User, 2015–2022 (USD Million)
Table 39 Europe: Market Size, By Application, 2015–2022 (USD Million)
Table 40 Germany: Market Size, By Type, 2015–2022 (USD Million)
Table 41 Germany: Market Size, By Application, 2015–2022 (USD Million)
Table 42 France: Market Size, By Type, 2015–2022 (USD Million)
Table 43 France: Market Size, By Application, 2015–2022 (USD Million)
Table 44 U.K.: Market Size, By Type, 2015–2022 (USD Million)
Table 45 U.K.: Market Size, By Application, 2015–2022 (USD Million)
Table 46 RoE: Market Size, By Type, 2015–2022 (USD Million)
Table 47 RoE: Market Size, By Application, 2015–2022 (USD Million)
Table 48 Asia-Pacific: Thrombectomy Devices Market Size, By Country, 2015–2022 (USD Million)
Table 49 Asia-Pacific: Thrombectomy Devices Market Size, By Type, 2015–2022 (USD Million)
Table 50 Asia-Pacific: Thrombectomy Devices Market Size, By End User, 2015–2022 (USD Million)
Table 51 Asia-Pacific: Thrombectomy Devices Market Size, By Application, 2015–2022 (USD Million)
Table 52 Japan: Market Size, By Type, 2015–2022 (USD Million)
Table 53 Japan: Market Size, By Application, 2015–2022 (USD Million)
Table 54 China: Market Size, By Type, 2015–2022 (USD Million)
Table 55 China: Market Size, By Application, 2015–2022 (USD Million)
Table 56 India: Thrombectomy Devices Market Size, By Type, 2015–2022 (USD Million)
Table 57 India: Thrombectomy Devices Market Size, By Application, 2015–2022 (USD Million)
Table 58 RoAPAC: Market Size, By Type, 2015–2022 (USD Million)
Table 59 RoAPAC: Market Size, By Application, 2015–2022 (USD Million)
Table 60 RoW: Thrombectomy Devices Market Size, By Country, 2015–2022 (USD Million)
Table 61 RoW: Market Size, By Type, 2015–2022 (USD Million)
Table 62 RoW: Thrombectomy Devices Market Size, By End User, 2015–2022 (USD Million)
Table 63 RoW: Market Size, By Application, 2015–2022 (USD Million)
Table 64 Latin America: Thrombectomy Devices Market Size, By Type, 2015–2022 (USD Million)
Table 65 Latin America: Thrombectomy Devices Market Size, By Application, 2015–2022 (USD Million)
Table 66 Middle East & Africa: Market Size, By Type, 2015–2022 (USD Million)
Table 67 Middle East & Africa: Market Size, By Application, 2015–2022 (USD Million)


List of Figures (75 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Primaries
Figure 3 Increase in Geriatric Population: By Country (2010 vs 2015)
Figure 4 Increase in the Proportion of Geriatric Individuals in the Overall Population: By Country (2011 vs 2015 vs 2030)
Figure 5 Percentage Increase in Geriatric Population, By Region (1980-2010 vs 2010–2040)
Figure 6 Bottom-Up Approach
Figure 7 Top-Down Approach
Figure 8 Data Triangulation
Figure 9 Global Market Size, By Type, 2017 vs 2022
Figure 10 Global Market Size, By Application, 2017 vs 2022
Figure 11 Global Market Size, By End User, 2017 vs 2022
Figure 12 Geographic Snapshot of the Global Thrombectomy Devices Market
Figure 13 Growing Target Patient Population to Propel the Demand for Thrombectomy Devices During the Forecast Period
Figure 14 North America Dominated the Thrombectomy Devices Market for All Application Segments in 2016
Figure 15 Mechanical Thrombectomy Devices Segment Will Continue to Dominate the Thrombectomy Devices Market Across All Regions in 2022
Figure 16 Hospitals & Surgical Centers Will Dominate the Thrombectomy Devices Market Across All Regions in 2017
Figure 17 China & India Estimated to Be the Fastest-Growing Countries in the Global Thrombectomy Devices Market
Figure 18 Thrombectomy Devices Market: Drivers, Restraints, Opportunities, and Challenges
Figure 19 Proportion of Geriatric Population to Total Population, By Country, (2012 vs 2020)
Figure 20 Government Healthcare Expenditure: Developed vs Developing Countries (2010–2015)
Figure 21 Ongoing Clinical Trials Across the Globe (As of December 2016)
Figure 22 Supply Chain Analysis: Thrombectomy Devices Industry
Figure 23 Porter’s Five Forces Analysis (2016)
Figure 24 Mechanical Thrombectomy Devices Segment to Witness Highest Market Growth During the Forecast Period
Figure 25 Stent Retrievers Segment to Dominate the Mechanical Thrombectomy Devices Market During the Forecast Period
Figure 26 North America to Hold Largest Share of the Ultrasonic Thrombectomy Devices Market During the Forecast Period
Figure 27 Cardiovascular Applications to Dominate the Thrombectomy Devices Market During the Forecast Period
Figure 28 North America to Hold Largest Share of the Peripheral Vascular Application Market During the Forecast Period
Figure 29 Hospitals & Surgical Centers to Register the Highest CAGR During the Forecast Period
Figure 30 North America: Market Snapshot
Figure 31 Europe: Market Snapshot
Figure 32 Asia-Pacific: Market Snapshot
Figure 33 RoW: Market Snapshot
Figure 34 MnM Dive – Vendor Comparison Matrix : Thrombectomy Devices Market
Figure 35 Analysis of Product Portfolio of Major Players in the Thrombectomy Devices Market (25 Players)
Figure 36 Business Strategy Adopted By Major Players in the Thrombectomy Devices Market (25 Players)
Figure 37 Geographic Revenue Mix of the Top Four Market Players (As of 2016)
Figure 38 Stryker Corporation: Company Snapshot (2016)
Figure 39 Stryker Corporation: Product Offering Scorecard
Figure 40 Stryker Corporation: Business Strategy Scorecard
Figure 41 Medtronic PLC: Company Snapshot (2016)
Figure 42 Medtronic PLC: Product Offering Scorecard
Figure 43 Medtronic PLC: Business Strategy Scorecard
Figure 44 Johnson & Johnson: Company Snapshot (2015)
Figure 45 Johnson & Johnson: Product Offering Scorecard
Figure 46 Johnson & Johnson: Business Strategy Scorecard
Figure 47 Terumo Corporation: Company Snapshot (2015)
Figure 48 Terumo Corporation: Product Offering Scorecard
Figure 49 Terumo Corporation: Business Strategy Scorecard
Figure 50 Boston Scientific Corporation: Company Snapshot (2016)
Figure 51 Boston Scientific Corporation: Product Offering Scorecard
Figure 52 Boston Scientific Corporation: Business Strategy Scorecard
Figure 53 Spectranetics Corporation: Company Snapshot (2016)
Figure 54 Spectranetics Corporation: Product Offering Scorecard
Figure 55 Spectranetics Corporation: Business Strategy Scorecard
Figure 56 Penumbra, Inc.: Company Snapshot (2016)
Figure 57 Penumbra, Inc.: Product Offering Scorecard
Figure 58 Penumbra, Inc.: Business Strategy Scorecard
Figure 59 Argon Medical Devices, Inc.: Product Offering Scorecard
Figure 60 Argon Medical Devices, Inc.: Business Strategy Scorecard
Figure 61 Edwards Lifesciences Corporation: Company Snapshot (2016)
Figure 62 Edwards Lifesciences Corporation: Product Offering Scorecard
Figure 63 Edwards Lifesciences Corporation: Business Strategy Scorecard
Figure 64 Teleflex Incorporated: Company Snapshot (2016)
Figure 65 Teleflex Incorporated: Product Offering Scorecard
Figure 66 Teleflex Incorporated: Business Strategy Scorecard
Figure 67 Straub Medical AG: Product Offering Scorecard
Figure 68 Straub Medical AG: Business Strategy Scorecard
Figure 69 BTG International Ltd.: Company Snapshot (2016)
Figure 70 BTG International Ltd.: Product Offering Scorecard
Figure 71 BTG International Ltd.: Business Strategy Scorecard
Figure 72 Phenox GmbH: Product Offering Scorecard
Figure 73 Phenox GmbH: Business Strategy Scorecard
Figure 74 Acandis GmbH: Product Offering Scorecard
Figure 75 Acandis GmbH: Business Strategy Scorecard

The global thrombectomy devices market is expected to reach a value of USD 1.45 Billion by 2022; growing at a CAGR of 6.7% during the forecast period. A number of factors such as growing target patient population, ongoing technological advancements, favorable medical reimbursements, rising demand for minimally invasive thrombectomy procedures, and increasing healthcare expenditure across emerging markets are driving the growth of the market. However, the stringent regulatory scenario, limited patient awareness resulting in delayed treatment for peripheral vascular diseases, and dearth of skilled & well-trained surgeons to perform thrombectomy procedures are the key challenges faced by majority of the thrombectomy devices manufacturers across the globe in the global market.

On the basis of type, the market is segmented into aspiration, mechanical/fragmentation, rheolytic/hydrodynamic, and ultrasonic thrombectomy devices. Based on type, the market is segmented into aspiration, mechanical, rheolytic, and ultrasonic thrombectomy devices. The ultrasonic thrombectomy devices segment is poised to be the fastest growing during the forecast period. The growing demand for ultrasonic thrombectomy devices can primarily be attributed to factors such as rising adoption of ultrasonic thrombectomy products by medical professionals, higher therapeutic efficacy for the treatment of deep vein thrombosis and pulmonary embolism, and its affordability.

On the basis of application, the global market is segmented into cardiovascular, peripheral vascular, and neurovascular applications. Peripheral vascular segment is expected to be the fastest growing in the market during the forecast period. This growth can be attributed to the rising availability of medical reimbursements for peripheral thrombectomy procedures across major markets, rising incidence of vascular disorders across the globe, growing geriatric population, ongoing technological advancements in the field of vascular ultrasound treatment, and rising awareness related to clinical efficacy of thrombectomy procedures in PVD treatment.

On the basis of end user, the global market is segmented into hospitals and surgical centers, ambulatory care centers, research laboratories & academic institutes, and other end users. The hospitals and surgical centers segment accounted for the largest share of the global thrombectomy devices market in 2017. The large share of this segment is attributed to the growing adoption of stent & clot retrievers for acute ischemic stroke treatment, expansion in clinical applications of ultrasonic thrombectomy for peripheral vascular treatment, rising incidence of chronic vascular diseases, and growing number of hospitals and surgical centers across emerging countries.

On the basis of region, North America accounted for the largest share of the market in 2017, while Asia-Pacific is projected to register the highest CAGR during the forecast period. Factors such as increasing adoption of technologically advanced thrombectomy products among surgeons, growing number of clinical trials, and medical reimbursements available in the U.S. for thrombectomy procedures are driving the growth of the North American thrombectomy devices market.

Thrombectomy Devices Market

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit https://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Medical Devices Markets on KnowledgeStore
Request Demo